venture capital

Women left out of VC club fight for their identity, pulling each other up one by one
Women left out of VC club fight for their identity, pulling each other up one by one
Fierce Biotech
venture capital
biotech
funding
Norwest Venture Partners
women
Flag link:
Slump in medtech VC activity continues as inflation keeps investors on the sidelines
Slump in medtech VC activity continues as inflation keeps investors on the sidelines
BioPharma Dive
Medtech
funding
venture capital
Flag link:
Orbital shows 2023’s venture funding scene is far from stratospheric
Orbital shows 2023’s venture funding scene is far from stratospheric
EP Vantage
RNA
funding
venture capital
Altos Labs
CureVac
EQRx
Hasten Biopharmaceutic
Orbital Therapeutics
Sana Biotechnology
Suzhou Abogen Biosciences
TORL BioTherapeutics
Flag link:
NYBC Ventures Launches $50M Fund to Accelerate Innovations in Blood and Cellular Therapies
NYBC Ventures Launches $50M Fund to Accelerate Innovations in Blood and Cellular Therapies
Yahoo/Businesswire
venture capital
NYBC Ventures
Flag link:
Joe Jimenez's Aditum finds fresh twist on old idea, paying $10M for autoimmune BTK inhibitor
Joe Jimenez's Aditum finds fresh twist on old idea, paying $10M for autoimmune BTK inhibitor
Fierce Biotech
venture capital
Joe Jimenez
Aditum Bio
autoimmune disease
Flag link:
A lean first quarter for venture-backed developers
A lean first quarter for venture-backed developers
EP Vantage
funding
venture capital
ArriVent Biopharma
Flare Therapeutics GSK
Hemab
Flag link:
Cure Ventures unveils inaugural $350M fund with focus on diligent seed rounds to de-risk new science
Cure Ventures unveils inaugural $350M fund with focus on diligent seed rounds to de-risk new science
Fierce Biotech
Cure Ventures
biotech
funding
venture capital
Flag link:
What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics
What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics
Fierce Biotech
M&A
GreenLight Biosciences
Egitis Therapeutics
venture capital
Flag link:
Biotech startups face ‘Series A cliff’ as venture capital stays cautious
Biotech startups face ‘Series A cliff’ as venture capital stays cautious
BioPharma Dive
funding
venture capital
Series A
Series B
Flag link:
Return of the megaround: Is biotech back from the brink?
Return of the megaround: Is biotech back from the brink?
Fierce Biotech
Rapport Therapeutics
Noema Pharma
Bicara Therapeutics
funding
venture capital
Flag link:
New VC Curie.bio makes its debut with $500m+ war chest
New VC Curie.bio makes its debut with $500m+ war chest
Pharmaphorum
venture capital
funding
Curie.bio
Flag link:
Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’
Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’
BioPharma Dive
biotech
venture capital
Dimension
digitization
Flag link:
The rise of venture debt and when biotechs should—and shouldn't—use it
The rise of venture debt and when biotechs should—and shouldn't—use it
Fierce Biotech
funding
biotech
venture capital
Flag link:
Medtech investments hold up despite market turmoil
Medtech investments hold up despite market turmoil
EP Vantage
venture capital
funding
Medtech
devices
AliveCor
Billiontoone
biolinq
Biofourmis
Cleerly
Delfi Diagnostics
Enable Injections
Kry International
Noah Medical
Saluda Medical
Flag link:
JPM23: Califf on accelerated approvals, biotech startups’ looming cliff and an explanation from Editas
JPM23: Califf on accelerated approvals, biotech startups’ looming cliff and an explanation from Editas
BioPharma Dive
JPMHC 2023
FDA
Robert Califf
funding
venture capital
biotech
Flag link:
Disappearing IPOs, building startups and closing deals: Views from an up-and-down year in biotech
Disappearing IPOs, building startups and closing deals: Views from an up-and-down year in biotech
BioPharma Dive
IPOs
venture capital
funding
Flag link:
J&J leads $85M investment in HistoSonics ahead of liver cancer device authorization
J&J leads $85M investment in HistoSonics ahead of liver cancer device authorization
Medtech Dive
JNJ
funding
venture capital
HistoSonics
liver cancer
Medtech
Edison
devices
JNJ Innovation
Flag link:
AbbVie links up with London VC firm to map out new anti-inflammatory companies
AbbVie links up with London VC firm to map out new anti-inflammatory companies
Fierce Biotech
AbbVie
venture capital
London
Deep Science Ventures
inflammatory diseases
Flag link:
VacV exits stealth with systemic oncolytic viral delivery tech and vision of immune system stimulation
VacV exits stealth with systemic oncolytic viral delivery tech and vision of immune system stimulation
Fierce Pharma
VacV Biotherapeutics
Vaccinia
oncolytic viruses
venture capital
Flag link:
Medtech bleeds corporate venture cash
Medtech bleeds corporate venture cash
EP Vantage
Medtech
venture capital
funding
Flag link:

Pages